On the quantitation of an agonist with dual but opposing components of action: Application to vascular endothelial relaxation

European Journal of Pharmacology

Volumn 670, Issue 1, 2011, Pages 204-207

  Lamarre, Neil S ^a   Parry, Tom ^b   Tallarida, Ronald J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ACORDA THERAPEUTICS INC   (United States)

Author keywords

Additivity; Angiotensin II; Dose equivalence; Endothelin 1; Endothelium; Isobole

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN 1;

ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; MALE; MATHEMATICAL MODEL; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ANGIOTENSIN II; ANIMALS; AORTA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG AGONISM; DRUG INTERACTIONS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; MALE; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION; VASODILATOR AGENTS;

EID: 80054755338     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.08.007     Document Type: Article

References (18)

1. A.P. Goldman, R.E. Delius, J.E. Deanfield, and D.J. Macrae Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations Ann. Thorac. Surg 60 1995 300 305
2. Y. Grabovsky, and R.J. Tallarida Isobolographic analysis for combinations of a full and partial agonist: curved isoboles J. Pharmacol. Exp. Ther 310 2004 981 986 (Pubitemid 39108918)
3. H. Izumi, Y. Makino, H. Mohtai, K. Shirakawa, and R.E. Garfield Comparison of nitric oxide and prostacyclin in endothelium-dependent vasorelaxation of human umbilical artery at midgestation Am. J. Obstet. Gynecol 175 1996 375 381 (Pubitemid 26390995)
4. L.E. Kim, J. Javellaud, and N. Oudart Endothelium-dependent relaxation of rabbit middle cerebral artery to a histamine H3-agonist is reduced by inhibitors of nitric oxide and prostacyclin synthesis Br. J. Pharmacol 105 1992 103 106
5. N. Lamarre, and R.J. Tallarida A quantitative study to assess synergistic interactions between urotensin II and angiotensin II European J. Pharmacol 586 2008 350 351
6. S. Loewe Die Mischiarnei Klin. Wochenschr 6 1927 1077 1085
7. S. Loewe Die quantitativen probleme der pharmakologie Ergebn. Physiol 27 1928 47 187
8. S. Loewe The problem of synergism and antagonism of combined drugs Arzneimittelforschung 3 1953 285 290
9. R.D. Shipley, and J.M. Muller-Delp Aging decreases vasoconstrictor responses of coronary resistance arterioles through endothelium-dependent mechanisms Cardiovasc. Res 66 2005 374 383 (Pubitemid 40471052)
10. R.J. Tallarida A further comment on testing for drug synergism Pain 51 1992 381 382
11. R.J. Tallarida Drug Synergism and Dose-Effect Data Analysis first ed. 2000 CRC Press LLC Boca Raton, FL
12. R.J. Tallarida Drug synergism: its detection and applications J. Pharmacol. Exp. Ther 298 2001 865 872 (Pubitemid 32761897)
13. R.J. Tallarida The interaction index: a measure of drug synergism Pain 98 2002 163 168 (Pubitemid 34722478)
14. R.J. Tallarida An overview of drug combination analysis with isobolograms J. Pharmacol. Exp. Ther 319 2006 1 7 (Pubitemid 44455105)
15. R.J. Tallarida Interactions between drugs and occupied receptors Pharmacol. Therapeut 113 2007 197 209 (Pubitemid 44969929)
16. R.J. Tallarida, and R.B. Raffa Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram Life Sci 58 1996 PL23-28
17. R.J. Tallarida, and R.B. Raffa The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations Pharmacol. Therapeut 127 2010 165 174
18. P.M. Vanhoutte, and T. Scott-Burden The endothelium in health and disease Tex. Heart I. J 21 1994 62 67 (Pubitemid 24111393)